Jejunal permeability and hepatic extraction of fluvastatin in humans (Q71828066)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8941022%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

title

Jejunal permeability and hepatic extraction of fluvastatin in humans (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8941022%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8941022%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

author name string

Sandström R

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8941022%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Ungell AL

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8941022%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Abrahamsson B

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8941022%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Knutson TW

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8941022%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Knutson L

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8941022%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Lennernäs H

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8941022%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

publication date

1 November 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8941022%20AND%20SRC:MED&resulttype=core&format=json

Clinical Pharmacology & Therapeutics

21 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8941022%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

volume

60

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8941022%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8941022%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

page(s)

493-503

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8941022%20AND%20SRC:MED&resulttype=core&format=json

By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease?

21 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990145-9

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990145-9

A receptor-mediated pathway for cholesterol homeostasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990145-9

Tissue selectivity of hydroxymethylglutaryl coenzyme A (HMG CoA) reductase inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990145-9

Physiological disposition of HMG-CoA-reductase inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990145-9

Does fluid flow across the intestinal mucosa affect quantitative oral drug absorption? Is it time for a reevaluation?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990145-9

The lack of effect of induced net fluid absorption on the in vivo permeability of terbutaline in the human jejunum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990145-9

Intestinal drug absorption during induced net water absorption in man; a mechanistic study using antipyrine, atenolol and enalaprilat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990145-9

Paracellular intestinal transport of six-carbon sugars is negligible in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990145-9

A practitioner's perspective of the role of quantitative structure-activity analysis in medicinal chemistry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990145-9

Permeability of small nonelectrolytes through lipid bilayer membranes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990145-9

Absorption of polyethylene glycols 600 through 2000: the molecular weight dependence of gastrointestinal and nasal absorption

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990145-9

The effect of L-leucine on the absorption of levodopa, studied by regional jejunal perfusion in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990145-9

Estimation of impurity profiles of drugs and related materials. 12. Isolation and identification of an isomeric impurity in danazol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990145-9

Determination of fluvastatin enantiomers and the racemate in human blood plasma by liquid chromatography and fluorometric detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990145-9

Regional rectal perfusion: a new in vivo approach to study rectal drug absorption in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990145-9

Anomalous parameter estimates in the one-compartment model with first-order absorption.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990145-9

Binding of fluvastatin to blood cells and plasma proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990145-9

In vivo inhibition profile of cytochrome P450TB (CYP2C9) by (±)-fluvastatin*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990145-9

Oral first-pass elimination of midazolam involves both gastrointestinal and hepatic CYP3A-mediated metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990145-9

Pharmacokinetics of fluvastatin after single and multiple doses in normal volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990145-9

A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990145-9

Disposition of pravastatin sodium, a tissue-selective HMG-CoA reductase inhibitor, in healthy subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990145-9

Hepatoselective carrier-mediated sodium-independent uptake of pravastatin and pravastatin-lactone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990145-9

Evidence for the absorption of bile acids in the proximal small intestine of normo- and hyperlipidaemic subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990145-9

10.1016/S0009-9236(96)90145-9

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8941022%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1 reference